Latest Regulatory Milestones News

Page 54 of 84
Anteris Technologies reported solid clinical progress with 130 patients implanted with its DurAVR heart valve and is gearing up for its pivotal PARADIGM trial with 79 qualified sites worldwide. The company also strengthened its leadership with two new board members amid ongoing FDA engagement.
Ada Torres
Ada Torres
12 Aug 2025
Anteris Technologies Global Corp. reported a $42.7 million net loss for the first half of 2025 amid advancing preparations for its pivotal DurAVR Transcatheter Heart Valve trial. The company’s recent IPO proceeds are fueling R&D and manufacturing scale-up as it targets regulatory approvals.
Ada Torres
Ada Torres
12 Aug 2025
Island Pharmaceuticals has raised $350,000 through an options exercise by substantial shareholder MWP Partners, reinforcing confidence in its antiviral drug development pipeline.
Ada Torres
Ada Torres
11 Aug 2025
Syntara Limited is set to update investors on the clinical progress of its lead drug candidate amsulostat, targeting myelofibrosis, in a webinar scheduled for 11 August 2025. The company highlights recent regulatory milestones and advancing trials.
Ada Torres
Ada Torres
11 Aug 2025
MAC Copper has secured a crucial regulatory green light from the South African Reserve Bank, advancing Harmony Gold’s proposed acquisition. Shareholders are now gearing up to vote on the deal at meetings scheduled for late August.
Maxwell Dee
Maxwell Dee
11 Aug 2025
Magnetite Mines Limited has announced a pro rata renounceable rights issue aiming to raise up to $2.65 million to advance its flagship Razorback iron ore project. The capital raise includes free attaching options and is partially underwritten, supporting key development milestones and strategic partnerships.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Magnetite Mines Limited has updated its Razorback Iron Ore Project, revealing a 6.6 billion tonne mineral resource and progressing key strategic partnerships and approvals to support green steelmaking ambitions.
Maxwell Dee
Maxwell Dee
8 Aug 2025
PYC Therapeutics has escalated dosing to the highest level in its Phase 1a trial of PYC-003 and begun dosing patients with Polycystic Kidney Disease, marking key progress toward regulatory milestones.
Ada Torres
Ada Torres
8 Aug 2025
VRX Silica Limited has secured approval for its Mining Proposal at the Arrowsmith North Silica Sand Project, marking a pivotal step toward production in a globally significant silica sand deposit.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Gibb River Diamonds reports strong Phase 1 grade control drilling results at the Neta Gold Prospect, confirming high-grade gold mineralisation from surface and setting the stage for imminent mining activities.
Maxwell Dee
Maxwell Dee
7 Aug 2025
Dundee Precious Metals has secured the Bosnian Competition Council's approval, clearing a major regulatory hurdle in its planned acquisition of Adriatic Metals. The deal now moves closer to completion pending shareholder and court approvals.
Maxwell Dee
Maxwell Dee
7 Aug 2025
Silex Systems Limited has announced a $145 million equity raise to fund the commercialisation of its SILEX laser uranium enrichment technology through its US joint venture, Global Laser Enrichment. The capital will support critical technology milestones and expansion into new isotope markets amid a global nuclear fuel renaissance.
Maxwell Dee
Maxwell Dee
7 Aug 2025